Deciphera Pharmaceuticals Inc logo

Deciphera Pharmaceuticals Inc

NAS:DCPH (USA)  
$ 15.00 +0.25 (+1.69%) 11:08 PM EST
P/E:
At Loss
P/B:
2.97
Market Cap:
$ 1.14B
Enterprise V:
$ 824.85M
Volume:
381.75K
Avg Vol (2M):
763.30K
Also Trade In:
Volume:
381.75K
Market Cap $:
1.14B
PE Ratio:
At Loss
Avg Vol (2M):
763.30K
Enterprise Value $:
824.85M
PB Ratio:
2.97

Business Description

Description
Deciphera Pharmaceuticals Inc is a biotechnology company, which develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological diseases. It holds a diverse pipeline of drug candidates that includes three clinical-stage and two research-stage programs. Its lead drug candidate DCC-2618 is designed to inhibit the full spectrum of mutant or amplified KIT and Pdgfra kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. In addition, it is also developing two other clinical-stage drug candidates, DCC-3014 and Rebastinib. Geographically all the operations function through the region of the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 11.15
Equity-to-Asset 0.75
Debt-to-Equity 0.09
Debt-to-EBITDA -0.16
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.99
Distress
Grey
Safe
Beneish M-Score -2.72
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 40.42
9-Day RSI 43.54
14-Day RSI 44.31
6-1 Month Momentum % -19.99
12-1 Month Momentum % 63.63

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.54
Quick Ratio 4.31
Cash Ratio 3.75
Days Inventory 785.2
Days Sales Outstanding 62.8
Days Payable 654.02

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -9.4

Financials (Next Earnings Date:2023-05-04 Est.)

DCPH's 30-Y Financials

How Deciphera Pharmaceuticals Inc (DCPH) Makes Its Money

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:DCPH

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Deciphera Pharmaceuticals Inc Executives

Details

Valuation chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 134.036
EPS (TTM) ($) -2.55
Beta 0.24
Volatility % 45.82
14-Day RSI 44.31
14-Day ATR ($) 0.669761
20-Day SMA ($) 15.2385
12-1 Month Momentum % 63.63
52-Week Range ($) 8.525 - 22.76
Shares Outstanding (Mil) 75.95

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Deciphera Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Deciphera Pharmaceuticals Inc Stock Events

Event Date Price($)
No Event Data

Deciphera Pharmaceuticals Inc Frequently Asked Questions

What is Deciphera Pharmaceuticals Inc(DCPH)'s stock price today?
The current price of DCPH is $15.00. The 52 week high of DCPH is $22.76 and 52 week low is $8.53.
When is next earnings date of Deciphera Pharmaceuticals Inc(DCPH)?
The next earnings date of Deciphera Pharmaceuticals Inc(DCPH) is 2023-05-04 Est..
Does Deciphera Pharmaceuticals Inc(DCPH) pay dividends? If so, how much?
Deciphera Pharmaceuticals Inc(DCPH) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1